vimarsana.com

Latest Breaking News On - Sulfate inhalation aerosol - Page 1 : vimarsana.com

Cipla Issues Voluntary Nationwide Recall of Six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) due to Container Defect

/PRNewswire/ Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as "Cipla"), today announced that its wholly-owned subsidiary Cipla US is.

Cipla customer servicePrnewswire cipla limitedDrug administrationAlbuterol sulfate inhalation aerosolSulfate inhalation aerosolBatch numberWatch adverse event reportingMedical pharmaceuticalsHealth care amp hospitalsProduct recalls

Cipla initiates voluntary recall of six inhaler batches in the US

Cipla initiates voluntary recall of six inhaler batches in the US
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Cipla united states incDrugmaker ciplaAlbuterol sulfate inhalationBatch numberAlbuterol sulfate inhalation aerosolSulfate inhalation aerosol

Cipla Issues Voluntary Nationwide Recall of Six Batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) Due to Container Defect

Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as "Cipla"), today announced that its wholly-owned subsidiary Cipla US is voluntarily recalling six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) manufactured in November 2021 to the consumer leve

New jerseyUnited statesHeena kanalCompany announcementCipla customer serviceCompany nameDrug administrationCompany contact informationCorporate communicationsCipla limitedAnnouncement dateSulfate inhalation aerosolIndia julyUnited states julyAlbuterol sulfate inhalation aerosolBatch number

Container Defect Prompts Recall of Albuterol Inhalers

Cipla has initiated a recall of 6 batches of Albuterol Sulfate Inhalation Aerosol, 90mcg (200 metered inhalation) due to a container defect.

Drug administration medwatchAlbuterol sulfate inhalation aerosolSulfate inhalation aerosolDrug administration

Albuterol Sulfate Inhalation Aerosol market Insights, Deep Analysis of Key Vendor in the Industry 2021-2027 – Business

iCrowdNewswire Feb 16, 2021 8:00 AM ET HNY Research has announced the Latest edition of “Albuterol Sulfate Inhalation Aerosol market” Report 2020 Opportunities, Challenges, Strategies and Forecasts 2027” . This report provides in-depth analysis of market statistic, market size, market growth, by product type, industry application, market trends and Covid-19 Impact on Global and Regional Market. The market research team projects that the Albuterol Sulfate Inhalation Aerosol market size will grow from XXX in 2021 to XX. The report also showcases Historical data from 2015 to 2020. Major Key Players profiled in the report : GSK,Merck & Co.,Teva Respiratory o Brief Introduction to the scope of research covered in the report.

United statesUnited kingdomNew zealandWorld health organizationAl qahirahSouth koreaRepublic ofSouth africaUnited arab emiratesPuerto ricoSaudi arabiaMerck coAlbuterol sulfateSulfate inhalation aerosolAlbuterol sulfate inhalation aerosolKey players

vimarsana © 2020. All Rights Reserved.